More Sharlee L, Kovochich Michael, Lyons-Darden Tara, Taylor Michael, Schulte Alexandra M, Madl Amy K
Cardno ChemRisk, 6720 S Macadam Ave Suite 150, Portland, OR 97219, USA.
Cardno ChemRisk, 30 North LaSalle St Suite 3910, Chicago, IL 60602, USA.
Nanomaterials (Basel). 2021 Mar 5;11(3):642. doi: 10.3390/nano11030642.
The exceptional physical and chemical properties of nickel nanomaterials have been exploited in a range of applications such as electrical conductors, batteries, and biomaterials. However, it has been suggested that these unique properties may allow for increased bioavailability, bio-reactivity, and potential adverse health effects. Thus, the purpose of this review was to critically evaluate data regarding the toxicity of oxidic nickel nanoparticles (nickel oxide (NiO) and nickel hydroxide (Ni(OH)) nanoparticles) with respect to: (1) physico-chemistry properties; (2) nanomaterial characterization in the defined delivery media; (3) appropriateness of model system and translation to potential human effects; (4) biodistribution, retention, and clearance; (5) routes and relevance of exposure; and (6) current research data gaps and likely directions of future research. Inhalation studies were prioritized for review as this represents a potential exposure route in humans. Oxidic nickel particle size ranged from 5 to 100 nm in the 60 studies that were identified. Inflammatory responses induced by exposure of oxidic nickel nanoparticles via inhalation in rodent studies was characterized as acute in nature and only displayed chronic effects after relatively large (high concentration and long duration) exposures. Furthermore, there is no evidence, thus far, to suggest that the effects induced by oxidic nickel nanoparticles are related to preneoplastic events. There are some data to suggest that nano- and micron-sized NiO particles follow a similar dose response when normalized to surface area. However, future experiments need to be conducted to better characterize the exposure-dose-response relationship according to specific surface area and reactivity as a dose metric, which drives particle dissolution and potential biological responses.
镍纳米材料卓越的物理和化学性质已在一系列应用中得到利用,如电导体、电池和生物材料等。然而,有人提出这些独特的性质可能会提高生物利用度、生物反应性,并带来潜在的健康不良影响。因此,本综述的目的是严格评估关于氧化镍纳米颗粒(氧化镍(NiO)和氢氧化镍(Ni(OH))纳米颗粒)毒性的数据,内容涉及:(1)物理化学性质;(2)在特定递送介质中的纳米材料表征;(3)模型系统的适用性以及对潜在人体影响的转化;(4)生物分布、滞留和清除;(5)暴露途径及其相关性;(6)当前研究的数据差距以及未来研究可能的方向。吸入研究被优先纳入综述,因为这代表了人类潜在的暴露途径。在所确定的60项研究中,氧化镍颗粒大小在5至100纳米之间。在啮齿动物研究中,通过吸入暴露于氧化镍纳米颗粒所引发的炎症反应本质上是急性的,只有在相对大量(高浓度和长时间)暴露后才会表现出慢性影响。此外,迄今为止,没有证据表明氧化镍纳米颗粒所引发的影响与肿瘤前病变事件有关。有一些数据表明,当按表面积归一化时,纳米级和微米级的NiO颗粒呈现相似的剂量反应。然而,未来需要进行实验,以便根据比表面积和反应性作为剂量指标,更好地表征暴露 - 剂量 - 反应关系,这种剂量指标会驱动颗粒溶解和潜在的生物反应。